University of Ioannina
Μελέτη παθοφυσιολογικών παραμέτρων του συνδρόμου άπνοιας κατά τον ύπνο
Abstract
dc:descriptionIntroduction: Obstructive Sleep Apnea (OSA) is one of the most widespreadsyndromes with sufferers from all ages. It is also known that OSA is directlylinked to obesity, as well as the incidence of Metabolic Syndrome (MS).Nevertheless, according to the bibliography on the subject, it is not clear whether the pathophysiological changes occurring to OSA patients are solely attributableto it irrespective of obesity or MS.Purpose: The aim of the study is to investigate the correlation of OSA, whethermild or severe, as it is expressed by the ΑΗΙ indicator, with somatometric data(cervice, hip, abdomen and hip perimeters), with obesity-generating fat tissuehormones, with sex/gender hormones, with thyroid gland hormones, with theIGFBP-1 growth factor, with inflammation indicators, with resistance toinsoulin, with hyperlipidemia, as well as Metabolic Syndrome characteristics.Material – Method: In the study, participated 131 patients (111 male, 21female), average age 55.4±12.4, average body mass index 34.3±11.2kg/m2 andaverage AHI indicator 44.7±26.3. Of those 131 patients, 75 (57.25%) sufferedfrom Metabolic Syndrome (according to ATP III criteria), while 56 (42.75%) didnot. Cervice, hip, abdomen and thigh perimeters were measured on all patients.Moreover, there were measurements of CRP, fibrinogen, ferritin, uric acid,cholesterol, triglycerides, HDL, glucose, insoulin, T3, free thyroxine, thyroidstimulating hormone, X-linked globin, sulfate dehydroepiandrosterone andtestosterone. Additionally, insoulin resistance was calculated through theHOMA-IR indicator. Finally, in 111 (95 male, 16 female) of the 131 patients,adinopectin, leptin and IGFBP-1 levels were measured.The participants were divided into two groups, those suffering only fromOSA, and those suffering from OSA and MS at the same time. Results: The results of the OSA correlations with the above parameters are asfollows:• AHI is correlated with BMI, cervice, hip, thigh and abdomen perimeters. Ofall the above correlations, cervice perimeter constitutes the determiningfactor of the OSA severity.• T3, FT4 and TSH figures are not affected in OSA sufferers. Consequently,the impact of hypothyroidism on OSA patients is low.• Uric acid levels are independent of the OSA indicator and are mostlyaffected by male gender and hemoglobin saturation on OSA patients withhigh levels of uric acid.• Obesity is linked / correlated to increased leptin levels, as well as lowIGFBP-1 levels, while OSA is only linked to low IGFBP-1 levels. Leptin isnot related to OSA.• Insoulin resistance (as measured through the HOMA-IR indicator) is loweron milder OSA sufferers (as expressed through AHI) AHI<20, as comparedto more severe OSA patients, AHI>20.• No correlation between the HOMA-IR indicator and obesity was found. No correlation among adinopectin, obesity and OSA was found. OSA patients’ testosterone levels are inversrely proportionate to body massindex (R2: 0.290; p:0.01). Age and OSA indicator are unrelated totestosterone levels.• Inflammation indicators (ferritin, fibrinogen, CRP) are increased in OSApatients, irrespective of Metabolic Syndrome coexistence. Ferritin,however, (p<0.01) increases more in OSA patients suffering from MetabilicSyndrome, as well than those suffering only from OSA. Nevertheless,values remain within the normal range.• HDL levels do not correlate with OSA or MS. OSA and MS patients haveincreased cholesterol levels (above normal) as compared to patientssuffering from OSA only, yet there is no statistically significant differencebetween these two groups. Triglycerides values are lower in OSA patientswithout MS (p<0.05) than those suffering from both OSA and MS.Nonetheless, values remain within normal levels in both groups.• SHBG is not affected in OSA patients whether they also suffer from MS ornot. DHEAS is inreased in OSA patients who do not suffer from MS incontrast to those who suffer from both syndroms, yet its value remains within normal levels.• Testosterone is increased in OSA patients (p<0.05) as compared tosimultaneous OSA and MS sufferers, yet its value remains within normallevels.• Insoulin resitance is higher in OSA and MS patients than it is in only OSAones with a statistically significant difference (p=0.001).• Homa-IR is increased when AHI>20.Conclusions:• The perimeter of the cervice determines the severity of the OSA syndrome.• The effect of hypothyroidism on OSA patients is low, and therefore, noneed to measure thyroid hormones in all sufferers arises.• It is hypoxia rather than AHI that affects uric acid levels on OSA sufferers.• OSA is related to lower levels of IGFBP-1.• Leptin and adiponectin are not related to OSA.• Leptin levels drop with obesity. There was no correlation betweenadiponectin and obesity.• Resistance to insoulin depends on the severity of the OSA syndrome and on MS. No correlation between resistance to insoulin and obesity was found.• Testosterone levels are not related to OSA, but to the body mass index. Moreover, they are lower in patients suffering from both OSA and MS thanin those suffering from OSA alone. Consequently, the diminished libidofrequently mentioned by OSA patients is attributable to obesity rather thanOSA.• OSA increases inflammatory indicators regardless of MS.• Ferritin levels are higher in OSA and MS patients.• OSA is not related to hyperlipidemia, yet OSA and MS sufferers tend todevelop it as compared to those suffering from OSA alone.• SHGB and DHEAS are not related to either OSA or MS.• Ηoma-IR is related to the severity of OSA (increases when AHI>20).
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lamprou, Kallirroi
- Λάμπρου, Καλλιρρόη
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39680